Prevalence and Viral Load of Human Parvovirus B19 (B19V) Among Blood Donors in South-East Brazil

Indian Journal of Hematology and Blood Transfusion

Volumn 32, Issue , 2016, Pages 323-325

  Slavov, Svetoslav Nanev ^a   Otaguiri, Katia Kaori ^a   Covas, Dimas Tadeu ^a   Kashima, Simone ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

B19V; Blood donors; Human parvovirus B19; Viral quantitation

Indexed keywords

VIRUS DNA;

ADULT; AGED; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; BRAZIL; DNA SEQUENCE; FEMALE; HUMAN; HUMAN PARVOVIRUS B19; LETTER; MALE; NONHUMAN; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; VIRUS DETECTION; VIRUS LOAD;

EID: 84944711867     PISSN: 09714502     EISSN: 09740449     Source Type: Journal    
DOI: 10.1007/s12288-015-0607-1     Document Type: Letter

References (15)

1. Heegaard ED, Brown KE (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505
2. Slavov SN, Haddad SK, Silva-Pinto AC, Amarilla AA, Alfonso HL, Aquino VH, Covas DT (2012) Molecular and phylogenetic analyses of human parvovirus B19 isolated from Brazilian patients with sickle Cell disease, beta-thalassemia major and healthy blood donors. J Med Virol 84:1652–1665
3. Juhl D, Steppat D, Görg S, Hennig H (2014) Parvovirus B19 infections and blood counts in blood donors. Transfus Med Hemother 41:52–59
4. Corcioli F, Zakrzewska K, Rinieri A, Fanci R, Innocenti M, Civinini R, De Giorgi V, Di Lollo S, Azzi A (2008) Tissue persistance of p23-3arvovirus B19 genotypes in asymptomatic persons. J Med Virol 80:2005–2011
5. Lefrère JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrère F, Girot R, Allain JP, Laperche S (2005) Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106:2890–2895
6. Matsukura H, Shibata S, Tani Y, Shibata H, Furuta RA (2008) Persistent infection by human parvovirus B19 in qualified blood donors. Transfusion 48:1036–1037
7. Corcoran A, Doyle S (2004) Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53:459–475
8. Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, Kiss JE, Shyamala V, Busch MP, National Heart, Lung, Blood Institute, Retrovirus Epidemiology Donor Study (REDS-II) (2007) Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 47:1756–1764
9. Thomas I, Di Giambattista M, Gérard C, Mathys E, Hougardy V, Latour B, Branckaert T, Laub R (2003) Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 84:300–307
10. Ke L, He M, Li C, Liu Y, Gao L, Yao F, Li J, Bi X, Lv Y, Wang J, Hirsch ML, Li W (2011) The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers. Transfusion 51:1909–1918
11. Kooistra K, Mesman HJ, de Waal M, Koppelman MH, Zaaijer HL (2011) Epidemiology of high-level parvovirus B19V viraemia among Dutch blood donors, 2003–2009. Vox Sang 100(3):261–266
12. Juhl D, Görg S, Hennig H (2014) Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors. Vox Sang 107:226–232
13. Lee TH, Kleinman SH, Wen L, Montalvo L, Todd DS, Wright DJ, Tobler LH, Busch MP, NHLBI, Retrovirus Epidemiology Donor Study-II (REDS-II) (2011) Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors. Transfusion 51:1896–1908
14. US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. (2009) Nucleic Acid Testing (NAT) to Reduce the Possible Risk of Human Parvovirus B19 Transmission by Plasma-Derived Products. Available via: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm078510.pdf
15. Tsitsikas DA, Gallinella G, Patel S, Seligman H, Greaves P, Amos RJ (2014) Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. Blood Rev 28:23–30